Clinical trial of sitafloxacin against non-gonococcal urethritis

Clinical trial of sitafloxacin against non-gonococcal urethritis - Clinical trial of STFX against NGU

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004509

Enrollment

500

Registered

2010-11-05

Start date

2010-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-gonococcal urethritis

Interventions

STFX 200mg/day 7days

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Outpatients with non-gonococcal urethritis between 20 and 65 years old. Patients who undersutand the study and agree with written informed consent. Ptients agree that they do not have sexual intercourse without using condom during the period of clinical trial.

Exclusion criteria

Exclusion criteria: Patients who have allegy to fluoroquinolones Patients with severe renal dysfunction Patients who have a history of epilepsy. Patients who have severe heart diseases including inchemic heart diseases or arrthythmia.

Design outcomes

Primary

Measure	Time frame
Microbiological efficacy of STFX against causative bacteria(mMycoplasma genitalium,Chlamydaia trachomatis,Ureaplasma urealyticum)is investigated in non-gonococcal urethritis.	—

Secondary

Measure	Time frame
Clinical efficacy of STFX is investigated in non-gonococcal urethritis. Validation of new nucleic acid amplification testing for detecting M.genitalium or U.urealyticum is validated. Antimicrobial susceptibility of M.genitalium or U.urealyticum Analysis of genome ralated to resistance to antimicrobials in M.genitalium	—

Countries

Japan

Contacts

Public ContactSatoshi Takahashi

Sapporo Medical university School of Medicine Department of Urology

(011)611-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026